Company attributes
Industry
B2X
Founder
Pitchbook URL
Legal Name
Sio Gene Therapies, Inc.
Legal classification
Date Incorporated
2015
Number of Employees (Ranges)
51 – 200
Email Address
patients@siogtx.com0
hr@siogtx.com0
info@siogtx.com0
investors@siogtx.com0
Full Address
130 West 42nd Street 26th Floor New York, NY 10036 United States0
11 TIMES SQUARE, 33RD FLOOR NEW YORK 10036 NEW YORK United States
CIK Number
Investors
IRS Number
853,863,3150
Founded Date
January 1, 2015
Total Funding Amount (USD)
110,000,000
Latest Funding Round Date
February 2017
Stock Symbol
SIOX0
Exchange
Board of Directors
CFO
Former CEO
Latest Funding Type
NAICS Code
325,4120
Patents Assigned (Count)
1
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
55,000,000
Previous Name
Axovant Sciences Ltd.0
Axovant Gene Therapies Ltd.0
Roivant Neurosciences Ltd.0
SIC Code
2,8340
Ticker Symbol
SIOX0
Wikidata ID
Sio Gene Therapies, Inc. is a clinical-stage pharmaceutical company. It is a company that develops gene therapies for treating neurological disorders.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
